BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18365416)

  • 1. Rescue splenectomy for severe acute antibody-mediated rejection.
    Locke JE; Zachary AA; Mohammed BS; Warren DS; Montgomery RA
    Clin Transpl; 2006; ():518-20. PubMed ID: 18365416
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolution of chronic antibody mediated-rejection: a case report.
    Cornell LD; Wong W; Saidman S; Collins AB; Colvin RB
    Clin Transpl; 2006; ():463-7. PubMed ID: 18365404
    [No Abstract]   [Full Text] [Related]  

  • 3. Pre-formed donor-specific alloantibodies (DSA) detected only by luminex technology using HLA-coated microspheres and causing acute humoral rejection and kidney graft dysfunction.
    Muro M; Llorente S; Gónzalez-Soriano MJ; Minguela A; Gimeno L; Alvarez-López MR
    Clin Transpl; 2006; ():379-83. PubMed ID: 18365392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue therapy for early antibody mediated rejection with a proteasome inhibitor: a case report.
    Manitpisitkul W; Wilson N; Cooper M; Gurk-Turner C; Hurley H; Rasetto F; KuKuruga D; Barth RN; Philosophe B
    Clin Transpl; 2009; ():461-3. PubMed ID: 20524315
    [No Abstract]   [Full Text] [Related]  

  • 5. Three cases of suspected antibody-mediated rejection.
    Sutherland SM; Sarwal M
    Clin Transpl; 2006; ():473-8. PubMed ID: 18365406
    [No Abstract]   [Full Text] [Related]  

  • 6. Early diagnosis and successful treatment of acute antibody-mediated rejection of a renal transplant.
    Yang YW; Lin WC; Wu MS; Lee PH; Tsai MK
    Exp Clin Transplant; 2008 Sep; 6(3):211-4. PubMed ID: 18954299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bortezomib use in chronic antibody-mediated allograft dysfunction: a report of three cases.
    Cooper JE; Wiseman AC; Chan L
    Clin Transpl; 2009; ():455-9. PubMed ID: 20524314
    [No Abstract]   [Full Text] [Related]  

  • 8. Usefulness of splenectomy for chronic active antibody-mediated rejection after renal transplantation.
    Ishida H; Omoto K; Shimizu T; Shirakawa H; Nishida H; Xiaobei L; Yamaguchi Y; Tanabe K
    Transpl Int; 2008 Jun; 21(6):602-4. PubMed ID: 18266769
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunoadsorption with protein A in humoral acute rejection of kidney transplants: multicenter experience.
    Mastrangelo F; Pretagostini R; Berloco P; Poli L; Cinti P; Patruno P; Alfonso L; Pompei L; Carboni F; Rizzelli S
    Transplant Proc; 1995 Feb; 27(1):892-5. PubMed ID: 7879221
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody cases.
    Poli F; Haworth S; Nocco A; Gotti E; Boschiero L; Dissegna E; Libetta C; Pellegrini C; Benazzi E; Scalamogna M
    Clin Transpl; 2006; ():483-8. PubMed ID: 18365408
    [No Abstract]   [Full Text] [Related]  

  • 11. Time of occurrence of kidney acute antibody-mediated allograft rejection/acute cellular rejection and cell senescence: implications for function outcome.
    Arvizu-Hernández M; Morales-Buenrostro LE; Vilatoba-Chapa M; Mancilla-Urrea E; Uribe-Uribe N; Avila-Casado MC; de Leo C; Arvizu A; Gonzalez JL; Torres J; Gabilondo B; Correa-Rotter R; Alberú J
    Transplant Proc; 2010 Sep; 42(7):2486-92. PubMed ID: 20832529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New faces of acute rejection in 2008].
    Legendre C
    Nephrol Ther; 2009 Jun; 5 Suppl 4():S297-300. PubMed ID: 19596353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft loss associated with late humoral rejection after renal transplantation.
    Sun Q; Li L
    Clin Transpl; 2006; ():521-5. PubMed ID: 18365417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C4d-positive acute antibody-mediated rejection due to anti-HLA-DP antibody: a tale of one patient and a review of the University of Wisconsin experience.
    Samaniego M; Mezrich J; Torrealba J; Lorentzen D; Schadde E; Djamali A; Zachariah M; Sollinger H; Pirsch J
    Clin Transpl; 2006; ():503-7. PubMed ID: 18365412
    [No Abstract]   [Full Text] [Related]  

  • 15. Rescue splenectomy in a case of humoral rejection in ABO-incompatible simultaneous liver-kidney transplantation.
    Tzvetanov I; Spaggiari M; Jeon H; Bhati C; Hassan S; Joseph J; Heinrich L; Thielke J; Setty S; Oberholzer J; Benedetti E
    Transplantation; 2012 Jan; 93(2):e1-2. PubMed ID: 22234314
    [No Abstract]   [Full Text] [Related]  

  • 16. Bortezomib for the treatment of de novo HLA antibody-related antibody mediated rejection.
    Al Meshari K
    Clin Transpl; 2009; ():385-6. PubMed ID: 20524302
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of antibody-mediated rejection after kidney transplantation.
    Sureshkumar KK; Oti IU; Baroody SC; Hussain SM; Carpenter BJ; Nghiem DD; Marcus RJ
    Transplant Proc; 2008 Jun; 40(5):1373-4. PubMed ID: 18589109
    [No Abstract]   [Full Text] [Related]  

  • 18. CMV infection in post kidney transplant recipient.
    Abdelrahman M; Karkar A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):481-2. PubMed ID: 19414958
    [No Abstract]   [Full Text] [Related]  

  • 19. The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection.
    Locke JE; Zachary AA; Haas M; Melancon JK; Warren DS; Simpkins CE; Segev DL; Montgomery RA
    Am J Transplant; 2007 Apr; 7(4):842-6. PubMed ID: 17391127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-mediated rejection: a single center experience at Tokyo Women's Medical University.
    Tanabe K; Ishida H; Omoto K; Shimizu T; Shirakawa H
    Clin Transpl; 2006; ():363-9. PubMed ID: 18365390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.